| A Study of a Weight Loss Intervention in People With Endometrial Cancer | Early 1 | Memorial Sloan Kettering Cancer Center | <1 mi |
| A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer | Phase 1 | Memorial Sloan Kettering Cancer Center | <1 mi |
| A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | Phase 2 | Children's Oncology Group | <1 mi |
| A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events | N/A | Cleerly, Inc. | <1 mi |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Phase 3 | Boehringer Ingelheim | <1 mi |
| A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight | Phase 3 | Eli Lilly and Company | <1 mi |
| Validating CGM for GDM | N/A | Icahn School of Medicine at Mount Sinai | <1 mi |
| Rare and Atypical Diabetes Network | — | University of South Florida | <1 mi |
| DISCOVERY of Risk Factors for Type 2 Diabetes in Youth | — | George Washington University | <1 mi |
| A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's | N/A | Compedica Inc | <1 mi |
| The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) | Phase 3 | Eli Lilly and Company | <1 mi |
| A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus | Phase 1 | Eli Lilly and Company | <1 mi |
| Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing | N/A | Reprise Biomedical, Inc. | <1 mi |
| Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes | N/A | Albert Einstein College of Medicine | <1 mi |
| Transformative Research in Diabetic Nephropathy | — | University of Pennsylvania | <1 mi |
| Medically Tailored Meals for Cardiovascular Health | N/A | Columbia University | <1 mi |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes | Phase 3 | Sanofi | <1 mi |
| Fenofibrate for Prevention of DR Worsening | Phase 3 | Jaeb Center for Health Research | <1 mi |
| Novel Digital Patient-Reported Outcomes Tool for Diabetes Management | N/A | NYU Langone Health | <1 mi |
| CHIME: Comparing Health Interventions for Maternal Equity | N/A | Stanford University | <1 mi |
| Texts for Diabetes Control Among Homeless Persons | N/A | George Washington University | <1 mi |
| Implementing an Effective Diabetes Intervention Among Low-Income Immigrants | N/A | NYU Langone Health | <1 mi |
| PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes | Phase 4 | Brigham and Women's Hospital | <1 mi |
| Different Doses of Naronapride Vs. Placebo in Gastroparesis | Phase 2 | Dr. Falk Pharma GmbH | <1 mi |
| A Study of GNTI-122 in Adults Recently Diagnosed With T1D | Phase 1 | GentiBio, Inc | <1 mi |
| PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life | — | University of Colorado, Denver | <1 mi |
| Bionic Pancreas in CFRD | Phase 3 | Jaeb Center for Health Research | <1 mi |
| DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes | Phase 4 | Ohio State University | <1 mi |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | Phase 1/2 | COUR Pharmaceutical Development Company, Inc. | <1 mi |
| A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin | Phase 3 | Eli Lilly and Company | <1 mi |
| RESET System Pivotal Trial (Rev F) | N/A | Morphic Medical Inc. | <1 mi |
| A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight | Phase 3 | Eli Lilly and Company | <1 mi |
| Cholesterol Lowering and Residual Risk in Diabetes, Type 1 | Phase 4 | NYU Langone Health | <1 mi |
| Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease | Phase 3 | Prokidney | <1 mi |
| Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes | Phase 2/3 | Jaeb Center for Health Research | <1 mi |
| T1D Pregnancy & Me | — | Jaeb Center for Health Research | <1 mi |
| CGM for the Early Detection and Management of Hyperglycemia in Pregnancy | N/A | Jaeb Center for Health Research | <1 mi |
| Cleaner Air for Lower Cardiometabolic Risk | N/A | NYU Langone Health | <1 mi |
| Graded Insulin Suppression Test P&F | Phase 1 | Columbia University | <1 mi |
| Diazoxide Suppression Test P&F Study | Phase 1 | Columbia University | <1 mi |
| Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) | — | Jaeb Center for Health Research | <1 mi |
| TrialNet Pathway to Prevention of T1D | — | University of South Florida | <1 mi |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes | Phase 3 | Novo Nordisk A/S | <1 mi |
| HLA Demographics Study in Adults With Type 1 Diabetes | — | GentiBio, Inc | <1 mi |
| Leveraging Videos and Community Health Workers to Address Social Determinants of Health in Immigrants | N/A | NYU Langone Health | <1 mi |
| ED Diabetes Screening and Outpatient Care | N/A | NYU Langone Health | <1 mi |
| Real World Evidence Clinical Utility Study of KidneyIntelX | — | Renalytix AI, Inc. | <1 mi |
| Pregnancy and Postpartum CGM in GDM | — | Icahn School of Medicine at Mount Sinai | <1 mi |
| Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels | Phase 1 | Michio Hirano, MD | <1 mi |
| Lifestyle Patterns and Glycemic Control | N/A | Columbia University | <1 mi |
| VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) | Phase 3 | Viking Therapeutics, Inc. | <1 mi |
| North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) | — | Columbia University | <1 mi |
| Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes | Phase 4 | VA Office of Research and Development | <1 mi |
| Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) | — | The Rogosin Institute | <1 mi |
| NYSCF Scientific Discovery Biobank | — | New York Stem Cell Foundation Research Institute | <1 mi |
| Liver Transplant CGM | — | Icahn School of Medicine at Mount Sinai | <1 mi |
| High Fructose Diet, the Gut Microbiome, and Metabolic Health | N/A | Icahn School of Medicine at Mount Sinai | <1 mi |
| Human Models of Selective Insulin Resistance: Alpelisib, Part I | Phase 1 | Columbia University | <1 mi |
| A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) | Phase 1/2 | GI Innovation, Inc. | <1 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes | Phase 3 | Eli Lilly and Company | 4 mi |
| MiniMed Fit Payload Wear Study | — | Medtronic Diabetes | 4 mi |
| A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes | Phase 2 | Zucara Therapeutics Inc. | 4 mi |
| GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes | N/A | Medtronic Diabetes | 4 mi |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis | Phase 2/3 | CSL Behring | 4 mi |
| Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility | — | Brooklyn Clinical Research | 5 mi |
| In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes | N/A | Cornell University | 5 mi |
| Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health. | — | Clindove Research LLC | 5 mi |
| Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy | — | iHealthScreen Inc | 9 mi |
| Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide | Phase 3 | Novo Nordisk A/S | 12 mi |
| Fresh Takes!: An Evaluation of the Impact of Receiving Fresh Food Boxes | N/A | Montefiore Medical Center | 12 mi |
| Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM) | N/A | Montefiore Medical Center | 12 mi |
| Regulation of Endogenous Glucose Production by Central KATP Channels | Phase 2 | Meredith Hawkins | 12 mi |
| Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes | Phase 3 | vTv Therapeutics | 12 mi |
| Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes | N/A | Boston Medical Center | 12 mi |
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | Phase 3 | Alessandro Doria | 12 mi |
| Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression | N/A | Albert Einstein College of Medicine | 12 mi |
| Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes | Phase 2/3 | Throne Biotechnologies Inc. | 12 mi |
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide | Phase 2 | Eli Lilly and Company | 13 mi |
| Registry for Stage 2 Type 1 Diabetes | — | Sanofi | 13 mi |
| A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy | Phase 2 | Boehringer Ingelheim | 13 mi |
| A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers | N/A | Integra LifeSciences Corporation | 16 mi |
| Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers | N/A | Piomic Medical | 16 mi |
| DFC 004 Biomarkers for Active Diabetic Foot Ulcers | — | University of Michigan | 16 mi |
| A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes | Phase 2 | Hoffmann-La Roche | 16 mi |
| Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial | N/A | Sonavex, Inc. | 17 mi |
| Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone | N/A | Capsicure, LLC | 17 mi |
| Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers | Phase 1/2 | Eluciderm Inc | 17 mi |
| Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy | — | Averitas Pharma, Inc. | 17 mi |
| Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge | N/A | NYU Langone Health | 19 mi |
| A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting | — | Bayer | 25 mi |
| CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations | N/A | Capsicure, LLC | 28 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes | Phase 3 | Eli Lilly and Company | 28 mi |
| Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes | N/A | Endogenex, Inc. | 28 mi |
| Extracellular Vesicles, Insulin Action, and Exercise | N/A | Rutgers, The State University of New Jersey | 28 mi |
| Exercise and Time of Day in Type 2 Diabetes | N/A | Rutgers, The State University of New Jersey | 28 mi |
| Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE) | N/A | Rutgers, The State University of New Jersey | 28 mi |
| Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED | N/A | Rutgers, The State University of New Jersey | 28 mi |
| Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) | N/A | Rutgers, The State University of New Jersey | 28 mi |
| Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients | N/A | Rutgers, The State University of New Jersey | 28 mi |
| Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes | Phase 3 | Kailera | 34 mi |
| Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes | Phase 3 | Kailera | 34 mi |
| A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus | — | Nuvance Health | 42 mi |
| Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) | Phase 2 | Sparrow Pharmaceuticals | 43 mi |
| Neurologic Stem Cell Treatment Study | N/A | MD Stem Cells | 45 mi |